The latest applications of exosome-mediated drug delivery in anticancer therapies

Zhiwei Wen1, Wei Zhang1, Wei Wu2

  • 1School of Pharmacy, Guilin Medical University, Guilin 541199, China.

Insights

Exosomes offer a natural solution for delivering anticancer drugs, overcoming limitations like short half-life and off-target effects for improved cancer therapy and immunotherapy.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Research

Background:

  • Anticancer drugs face challenges including short half-life, poor cellular uptake, and off-target toxicity.
  • Exosomes, natural intercellular messengers, present unique advantages over synthetic carriers for drug delivery.
  • These cell-derived vesicles offer organotropic properties and minimal side effects.

Purpose of the Study:

  • To review the characteristics of exosomes for anticancer drug delivery.
  • To explore strategies for using exosomes as carriers in cancer therapy.
  • To highlight recent advancements in exosome-based cancer treatment.

Main Methods:

  • Literature review of exosome properties and applications in drug delivery.
  • Analysis of exosome-mediated delivery mechanisms for anticancer agents.
  • Synthesis of current research on exosome engineering for targeted cancer therapy.

Main Results:

  • Exosomes demonstrate stable, efficient, and selective delivery of anticancer drugs.
  • Their natural origin and organotropic functions enhance therapeutic efficacy.
  • Exosomes show potential in improving cancer immunotherapy outcomes.

Conclusions:

  • Exosomes are promising natural nanocarriers for overcoming limitations in traditional anticancer drug delivery.
  • Utilizing exosomes can enhance the effectiveness and safety of cancer treatments.
  • Further research into exosome-based systems is crucial for advancing cancer therapy.

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K